Reference health
Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia
37/37 checkable references clean · checked 2026-07-24
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
The 37 checked references that resolve
resolves10.1172/JCI17725
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
resolves10.1126/science.1470919
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
resolves10.1073/pnas.061029898
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB
<sub>1</sub>
receptor
resolves10.1124/pr.54.2.161
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
resolves10.1038/sj.bjp.0704767
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol
resolves10.1016/S0140-6736(05)66348-9
Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors
resolves10.1096/fj.04-3177fje
The CB1 receptor antagonist rimonabant reverses the diet‐induced obesity phenotype through the regulation of lipolysis and energy balance
resolves10.1124/mol.63.4.908
The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells
resolves10.1016/S0140-6736(05)66374-X
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
resolves10.1001/jama.285.19.2486
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
resolves10.1161/hc4401.098490
Comparison of Various Electrophoretic Characteristics of LDL Particles and Their Relationship to the Risk of Ischemic Heart Disease
resolves10.7326/0003-4819-133-2-200007180-00008
Reduction in Obesity and Related Comorbid Conditions after Diet-Induced Weight Loss or Exercise-Induced Weight Loss in Men
resolves10.1161/01.ATV.10.4.497
Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
resolves10.2337/diacare.19.6.629
The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men
resolves10.1016/S0002-9149(01)01448-5
Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management∗∗This article represents one side of a debate on the role of lipid subfractions in cardiovascular risk management; the opposing argument can be found in the accompanying article by Terje R. Pedersen, MD, PhD.
resolves10.1161/01.CIR.0000132467.45278.59
Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?
resolves10.1161/hc0502.103331
Weight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Women
resolves10.1161/01.ATV.21.6.968
Energy Restriction and Weight Loss on Very-Low-Fat Diets Reduce C-Reactive Protein Concentrations in Obese, Healthy Women
resolves10.1038/31701
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
resolves10.2337/diabetes.46.10.1594
Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study
resolves10.1161/01.HYP.27.1.125
Decrease in Intra-Abdominal Visceral Fat May Reduce Blood Pressure in Obese Hypertensive Women
resolves10.1210/jc.2004-1711
Adiponectinemia in Visceral Obesity: Impact on Glucose Tolerance and Plasma Lipoprotein and Lipid Levels in Men
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-24 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1056/nejmoa044537"><img src="https://citestamp.com/citestamped/10.1056/nejmoa044537/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1056/nejmoa044537)